StonvexLoading…
StonvexStonvexStonvexCore line items from APLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.00B | $781.37M | $396.59M | $75.42M |
Operating Income | $55.43M | $-164.98M | $-517.12M | $-594.61M |
Net Income | $22.39M | $-197.88M | $-528.63M | $-652.17M |
EPS (Diluted) | $0.20 | $-1.60 | $-4.45 | $-6.15 |
Total Assets | $1.08B | $885.05M | $788.73M | $760.22M |
Total Liabilities | $705.11M | $656.51M | $594.21M | $590.35M |
Cash & Equivalents | $466.23M | $411.29M | $351.19M | $551.80M |
Free Cash Flow OCF − CapEx | $45.01M | $-88.27M | $-595.51M | $-515.27M |
Shares Outstanding | 126.62M | 124.50M | 119.56M | 110.77M |